| Parkinson's Disease Mechanisms and Treatments | Lifetime | 9 | AU 1 | 99.93 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 20 | AU 1 | 99.85 |
| Alzheimer's disease research and treatments | Lifetime | 53 | AU 3 | 99.83 |
| Nuclear Receptors and Signaling | Lifetime | 16 | AU 1 | 99.66 |
| Neurological diseases and metabolism | Lifetime | 24 | AU 1 | 99.55 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 121 | AU 4 | 99.39 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 39 | AU 3 | 99.36 |
| Alcoholism and Thiamine Deficiency | Lifetime | 22 | AU 2 | 98.68 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 118 | AU 3 | 99.14 |
| Ginkgo biloba and Cashew Applications | Lifetime | 22 | AU 1 | 98.69 |
| Dementia and Cognitive Impairment Research | Lifetime | 255 | AU 17 | 99.18 |
| Neurological and metabolic disorders | Lifetime | 63 | AU 3 | 98.27 |
| Genetic Neurodegenerative Diseases | Lifetime | 186 | AU 4 | 98.83 |
| Nerve injury and regeneration | Lifetime | 214 | AU 3 | 98.47 |
| RNA regulation and disease | Lifetime | 263 | AU 6 | 97.51 |
| S100 Proteins and Annexins | Lifetime | 329 | AU 11 | 96.74 |
| Lysosomal Storage Disorders Research | Lifetime | 317 | AU 10 | 96.81 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 926 | AU 32 | 96.66 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 589 | AU 18 | 95.95 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 742 | AU 31 | 94.23 |
| melanin and skin pigmentation | Lifetime | 901 | AU 24 | 92.92 |
| Prion Diseases and Protein Misfolding | Lifetime | 768 | AU 23 | 90.88 |
| Hallucinations in medical conditions | Lifetime | 122 | AU 14 | 81.49 |
| Restless Legs Syndrome Research | Lifetime | 946 | AU 20 | 80.18 |
| Cerebrovascular and genetic disorders | Lifetime | 882 | AU 25 | 76.33 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 11 | AU 1 | 99.66 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 23 | AU 1 | 99.27 |
| Nuclear Receptors and Signaling | 2021-2025 | 14 | AU 1 | 94.50 |
| Alzheimer's disease research and treatments | 2021-2025 | 226 | AU 6 | 97.46 |
| Lysosomal Storage Disorders Research | 2021-2025 | 174 | AU 4 | 91.55 |
| Neurological diseases and metabolism | 2021-2025 | 115 | AU 4 | 89.15 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 995 | AU 20 | 88.76 |
| Ginkgo biloba and Cashew Applications | 2021-2025 | 51 | AU 1 | 86.15 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 365 | AU 28 | 87.48 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 749 | AU 37 | 82.52 |
| Cellular transport and secretion | 2021-2025 | 647 | AU 16 | 75.70 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 989 | AU 53 | 76.84 |
| Restless Legs Syndrome Research | 2021-2025 | 524 | AU 9 | 57.21 |
| Spatial Neglect and Hemispheric Dysfunction | 2021-2025 | 238 | AU 12 | 56.70 |
